Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul 1:8:655763.
doi: 10.3389/fmed.2021.655763. eCollection 2021.

Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19

Driss Laghlam  1 , Ghilas Rahoual  1 , Julien Malvy  1 , Philippe Estagnasié  1 , Alain Brusset  1 , Pierre Squara  1
Affiliations

Use of Almitrine and Inhaled Nitric Oxide in ARDS Due to COVID-19

Driss Laghlam et al. Front Med (Lausanne). .

Abstract

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is manifested by an acute respiratory distress syndrome (ARDS) with intense inflammation and endothelial dysfunction leading to particularly severe hypoxemia. We hypothesized that an impaired hypoxic pulmonary vasoconstriction aggravates hypoxemia. The objective of the study was to test the effect of two pulmonary vasoactive drugs on patient oxygenation. Methods: Observational, single-center, open-label study in one intensive care unit (ICU) of the Paris area, realized in April 2020. Eligible patients had coronavirus disease 2019 (COVID-19) and moderate to severe ARDS [arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) <200 mmHg] despite conventional protective ventilation. Exclusion criteria included pulmonary artery hypertension defined by a pulmonary artery systolic pressure (PAPs) >45 mmHg. The assessment of oxygenation was based on PaO2/FiO2 at (1) baseline, then after (2) 30 min of inhaled nitric oxide (iNO) 10 ppm alone, then (3) 30 min combination of iNO + almitrine infusion 8 μg/kg/min, then (4) 30 min of almitrine infusion alone. Results: Among 20 patients requiring mechanical ventilation during the study period, 12 met the inclusion criteria. Baseline PaO2/FiO2 was 146 ± 48 mmHg. When iNO was combined with almitrine, PaO2/FiO2 rose to 255 ± 90 mmHg (+80 ± 49%, p = 0.005), also after almitrine alone: 238 ± 98 mmHg (+67 ± 75%, p = 0.02), but not after iNO alone: 185 ± 73 mmHg (+30 ± 5%, p = 0.49). No adverse events related to almitrine infusion or iNO was observed. Conclusion: Combining iNO and infused almitrine improved the short-term oxygenation in patients with COVID-19-related ARDS. This combination may be of interest when first-line therapies fail to restore adequate oxygenation. These findings argue for an impaired pulmonary hypoxic vasoconstriction in these patients.

Keywords: COVID-19; acute respiratory distress syndrome; almitrine; mechanical ventilation; nitric oxide.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Arterial partial pressure of oxygen/fraction of inspired oxygen (PaO2/FiO2) evolution, *comparison from baseline.
See this image and copyright information in PMC

References

    1. Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, et al. . Acute respiratory distress syndrome: the Berlin Definition. JAMA. (2012) 307:2526–33. 10.1001/jama.2012.5669 - DOI - PubMed
    1. Gattinoni L, Chiumello D, Rossi S. COVID-19 pneumonia: ARDS or not? Crit Care. (2020) 24:154. 10.1186/s13054-020-02880-z - DOI - PMC - PubMed
    1. Evans PC, Ed Rainger G, Mason JC, Guzik TJ, Osto E, Stamataki Z, et al. . Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science. Cardiovasc Res. (2020) 116:2177–84. 10.1093/cvr/cvaa230 - DOI - PMC - PubMed
    1. Villar J, Martin-Rodriguez C, Dominguez-Berrot AM, Fernandez L, Ferrando C, Soler JA, et al. . A quantile analysis of plateau and driving pressures: effects on mortality in patients with acute respiratory distress syndrome receiving lung-protective ventilation. Crit Care Med. (2017) 45:843–50. 10.1097/CCM.0000000000002330 - DOI - PubMed
    1. Amato MB, Barbas CS, Medeiros DM, Magaldi RB, Schettino GP, Lorenzi-Filho G, et al. . Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med. (1998) 338:347–54. 10.1056/NEJM199802053380602 - DOI - PubMed